Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Focalin LA: Phase III; approved in the U.S. for ADHD

CELG partner NVS began a U.S. Phase

Read the full 79 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE